Methodist Hospital Research Institute

Houston, Texas 77030

0 studies enrolling now · 13 studies all time

What they study most

Bone Metastases, Cerebral Aneurysm, Coronary Artery Disease, Crohn Disease, Heart Failure, Ischemic Stroke, Left Ventricular Dysfunction, Lymphoma, B-Cell, Metastatic Breast Cancer, Renal Cell Carcinoma, Spasticity, Sudden Cardiac Death

Studies at this site

• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early
• A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy — Completed
• Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy — Completed
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed
• BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma — Completed
• A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy — Completed
• ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain — Stopped early
• Hydrogel Endovascular Aneurysm Treatment Trial — Completed
• Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter — Completed
• DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation — Stopped early
• Long-term Surveillance of the MedStream Programmable Infusion System — Stopped early
• A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) — Completed
• Study to Examine the Effects of MultiStem in Ischemic Stroke — Completed